Skip to content

Clinical trials

Terminated Leukemia, Lymphocytic, Chronic, B-Cell trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Status: Terminated Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20081
20111
20121
20132
20171
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences3
Novartis Pharmaceuticals2
Biogen1
Cephalon1
European Organisation for Research and Treatment of Cancer - EORTC1
German CLL Study Group1
Incyte Corporation1
University of Ulm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell11
Leukemia4
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3
Lymphoma, Non-Hodgkin3
Waldenstrom Macroglobulinemia3
Blast Crisis1
Burkitt Lymphoma1
Congenital Abnormalities1
Fever1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.